Matheson is advising Royalty Pharma on its $7.3 billion cash offer for Elan Corporation plc, the Irish biotechnology company. The Matheson team is led by Tim Scanlon, George Brady and Fergus Bolster.
Royalty Pharma made an announcement of a firm intention to make the offer on 15 April 2013. Elan is listed on NYSE and the Irish Stock Exchange.
Matheson continues to be selected as the law firm of choice on significant Irish corporate transactions. Matheson recently advised Eaton Corporation plc on its $11.8 billion acquisition of Cooper Industries. This was the largest single M&A transaction in Ireland during 2012 and was named ‘Most Innovative Deal of the Year’ at the Finance Dublin 2013 Awards.
The firm also recently advised on the sale of the country’s biggest life and pensions provider Irish Life to Canada Life parent, Great-West Lifeco. The Financial Institutions Group at Matheson, led by partner Tim Scanlon, advised Ireland’s Minister for Finance on the €1.3 billion sale, which has been described as a “historic transaction.”
Matheson previously advised the Minister of Finance on the initial auction process for the sale of Irish Life in and its subsequent acquisition by the State from the Irish Life and Permanent Group in June 2012.
Matheson is the law firm of choice for international companies and financial institutions doing business in and through Ireland.
